BDBM531360 (3S,5R)-5-((6-(2-Hydroxy-6-methyl-4-(trifluoromethyl)phenyl)pyridazin-3-yl)amino)-1-methylpiperidin-3-ol::US11208399, Example 97

SMILES CN1C[C@@H](O)C[C@H](C1)Nc1ccc(nn1)-c1c(C)cc(cc1O)C(F)(F)F

InChI Key InChIKey=ADVVBDGTOAVKNX-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 531360   

TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandPNGBDBM531360(US11208399, Example 97 | (3S,5R)-5-((6-(2-Hydroxy-...)
Affinity DataIC50: 7.60nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
5/2/2022
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Novartis

US Patent
LigandPNGBDBM531360(US11208399, Example 97 | (3S,5R)-5-((6-(2-Hydroxy-...)
Affinity DataIC50: 1.00E+5nMAssay Description:Monocytic THP-1 cells were maintained according to providers' instructions in RPMI media as described above. Undifferentiated cells were plated a...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
5/2/2022
Entry Details
US Patent